相关实验视频
Updated: May 5, 2026

07:16
Biochemical Titration of Glycogen In vitro
Published on: November 24, 2013
28.5K
了解第九类糖原储存疾病:以临床为重点的系统审查 - - 为什么它不是良性的,需要警
Egidio Candela1,2, Giulia Montanari3, Andrea Zanaroli3
1Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Genes
|May 28, 2025
概括
糖原储存疾病类型IX (GSD IX) 在亚型中呈现出不同的临床特征,其中IXc是最具侵略性的. 本次审查强调了对GSD IX患者进行准确诊断和多学科护理的需要.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 糖原储存疾病第九型 (GSD IX) 是一种遗传性代谢障碍,由酸化酶激酶缺乏引起.
- 尽管GSD IX在糖原储存疾病中很常见,但仍未得到充分研究.
研究的目的:
- 进行对临床研究的系统审查 糖原储存疾病第九类型 (GSD IX).
- 分析与GSD IX亚型相关的临床谱和诊断挑战.
主要方法:
- 在遵守PRISMA指南的基础上进行系统审查.
- 包括到2024年12月31日发表的关于GSD IX的人类临床研究,来源于SCOPUS和PubMed.
- 分析了400名GSD IX患者的临床数据,这些数据涉及各个亚型 (IXa,IXc,IXb,IXd).
主要成果:
- 在GSD IX亚型中临床表现的显著变化.
- 在IXa,IXb和IXc中,肝壮病和过氨基酶升高是常见的,而肌肉参与 (CPK升高) 则是IXd的特征.
- 在IXa,IXb和IXc观察到禁食低血糖和生长延迟,IXd显示出延迟发病和较轻的症状.
结论:
- GSD IX表现出广泛的表型变异性,需要准确的诊断分类和长期的多学科随访.
- 亚型IXc表现出最具侵略性的临床过程,而IXd呈现出延迟发病和肌肉特异性症状.
- 需要进一步的研究,以了解系统性参与 (骨,脏) 并建立基于证据的治疗策略GSD IX.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Overview of Carbohydrate Metabolism
4.5K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.5K
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type I Diabetes III: Clinical Manifestations
31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
32
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32

